Drug or treatment
Nipocalimab clinical trials
As of November 12, 2026, Find a Trial lists 9 clinical trials of Nipocalimab that are recruiting, at sites in 41 countries (most in United States (8), Poland (6), Germany (6)). By phase: Phase 3 (6), Phase 2/3 (2), Phase 1 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 9Clinical trials
- 41Countries
Newest trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Nipocalimab in breast milk after a single IV dose in healthy lactating women | Phase 1 | Salt Lake City, Utah | Recruiting | Jun 25, 2026 |
| Nipocalimab for adults with moderate to severe systemic lupus erythematosus | Phase 3 | Beverly Hills, California and 271 other locations | Recruiting | Feb 27, 2026 |
| Nipocalimab versus efgartigimod for generalized myasthenia gravis | Phase 3 | Fullerton, California and 30 other locations | Recruiting | Oct 16, 2025 |
| Evaluating nipocalimab and IVIG for preventing fetal and neonatal thrombocytopenia | Phase 3 | Birmingham, Alabama and 37 other locations | Recruiting | Aug 1, 2024 |
| Evaluating nipocalimab for preventing fetal and neonatal alloimmune thrombocytopenia | Phase 3 | Leuven and 20 other locations | Recruiting | Jun 10, 2024 |
| Nipocalimab treatment for pregnant women at risk of severe fetal anemia | Phase 3 | La Jolla, California and 68 other locations | Recruiting | Jun 22, 2023 |
| Evaluating nipocalimab for adults with chronic inflammatory demyelinating polyneuropathy | Phase 2/3 | Centennial, Colorado and 119 other locations | Recruiting | Apr 14, 2022 |
| Nipocalimab treatment for children with generalized myasthenia gravis | Phase 2/3 | Phoenix, Arizona and 18 other locations | Recruiting | Mar 3, 2022 |
| Evaluating Nipocalimab for Adults with Generalized Myasthenia Gravis | Phase 3 | Paradise Valley, Arizona and 111 other locations | Recruiting | Jul 7, 2021 |
All recruiting trials (9)
-
Nipocalimab in breast milk after a single IV dose in healthy lactating women
This study tests how much nipocalimab shows up in breast milk after a single IV dose in healthy breastfeeding women.
-
Nipocalimab for adults with moderate to severe systemic lupus erythematosus
This trial tests nipocalimab versus placebo in adults with moderate to severe lupus to see if it reduces disease activity and symptoms.
-
Nipocalimab versus efgartigimod for generalized myasthenia gravis
This trial will test whether nipocalimab or efgartigimod works better to reduce muscle weakness in adults with AChR-positive generalized myasthenia gravis who have meaningful symptoms despite stable therapy.
-
Evaluating nipocalimab and IVIG for preventing fetal and neonatal thrombocytopenia
This study is testing if a new treatment called nipocalimab can help pregnant women with a history of fetal and neonatal thrombocytopenia keep their babies' platelet levels safe compared to standard treatment with IVIG.
-
Evaluating nipocalimab for preventing fetal and neonatal alloimmune thrombocytopenia
This study is testing whether nipocalimab can help pregnant women with a history of a blood condition called fetal and neonatal alloimmune thrombocytopenia prevent serious problems for their babies.
-
Nipocalimab treatment for pregnant women at risk of severe fetal anemia
This study is testing if nipocalimab can help pregnant women at risk of having babies with severe anemia due to a past condition, to see if it improves the health of their newborns.
-
Evaluating nipocalimab for adults with chronic inflammatory demyelinating polyneuropathy
This study is testing a new treatment called nipocalimab to see if it can help adults with chronic inflammatory demyelinating polyneuropathy avoid relapses and feel better.
-
Nipocalimab treatment for children with generalized myasthenia gravis
This study is testing a new treatment called nipocalimab to see if it can help children with generalized myasthenia gravis who haven't responded well to other therapies.
-
Evaluating Nipocalimab for Adults with Generalized Myasthenia Gravis
This study is testing a new drug called nipocalimab to see if it can help adults with generalized myasthenia gravis feel stronger and improve their daily activities compared to a placebo.
Quick answers
How many clinical trials of Nipocalimab are recruiting right now?
9, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 41 countries. The most sites are in United States (8 trials), Poland (6 trials), Germany (6 trials), Italy (6 trials), Spain (6 trials). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 3: 6, Phase 2/3: 2, Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.